Edgewise Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/14/2025 | 15.02 M | $401.08 M | 0.00% | 16.01% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 8.91 M | $237.87 M | 0.00% | 9.50% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.48 M | $172.99 M | 1.34% | 6.91% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 6.16 M | $164.36 M | 5.41% | 6.56% |
| NOVO HOLDINGS A/S | 02/14/2025 | 5.00 M | $133.50 M | -9.91% | 5.33% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 4.98 M | $133.04 M | 9.33% | 5.31% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 4.49 M | $119.99 M | 61.12% | 4.79% |
| VANGUARD GROUP INC | 02/11/2025 | 4.47 M | $119.26 M | -1.09% | 4.76% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 3.41 M | $90.95 M | 0.00% | 3.63% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 2.69 M | $71.70 M | 15.24% | 2.86% |
| BRAIDWELL LP | 02/14/2025 | 2.33 M | $62.27 M | 19.09% | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 2.08 M | $55.50 M | 16.70% | 2.22% |
| STATE STREET CORP | 02/14/2025 | 1.72 M | $45.81 M | 1.81% | 1.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.60 M | $42.74 M | 0.06% | 1.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.49 M | $39.88 M | -23.53% | 1.59% |
| BELLEVUE GROUP AG | 02/14/2025 | 1.43 M | $38.15 M | 0.00% | 1.52% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.27 M | $33.94 M | -55.13% | 1.36% |
| VIKING GLOBAL INVESTORS LP | 02/14/2025 | 1.22 M | $32.71 M | -17.29% | 1.31% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 1.08 M | $28.82 M | 17.68% | 1.15% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 1.07 M | $28.61 M | 7.09% | 1.14% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 02/13/2025 | 1.03 M | $27.51 M | -33.69% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 888,968 | $23.74 M | -9.94% | 0.95% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 780,639 | $20.84 M | 100.00% | 0.83% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 770,353 | $20.57 M | -17.56% | 0.82% |
| SIREN, L.L.C. | 02/14/2025 | 734,343 | $19.61 M | 81.72% | 0.78% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 729,923 | $19.49 M | 0.42% | 0.78% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 710,421 | $18.97 M | -35.45% | 0.76% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 686,371 | $18.33 M | 50.74% | 0.73% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 585,000 | $15.62 M | 100.00% | 0.62% |
| WOODLINE PARTNERS LP | 02/14/2025 | 567,218 | $15.14 M | 7.46% | 0.60% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 550,000 | $14.69 M | 100.00% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 537,359 | $14.35 M | 2.93% | 0.57% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 480,000 | $12.82 M | -8.13% | 0.51% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 428,858 | $11.45 M | 58.60% | 0.46% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 402,773 | $10.75 M | 4.68% | 0.43% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 400,000 | $10.68 M | -11.11% | 0.43% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 381,173 | $10.18 M | -41.99% | 0.41% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 369,442 | $9.86 M | 180.11% | 0.39% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 346,891 | $9.26 M | -28.06% | 0.37% |
| AMUNDI | 02/07/2025 | 341,687 | $8.69 M | 127.16% | 0.36% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 301,241 | $8.04 M | 100.00% | 0.32% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 300,013 | $8.01 M | -41.39% | 0.32% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 300,000 | $8.01 M | 100.00% | 0.32% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 300,000 | $8.01 M | -40.00% | 0.32% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 298,200 | $7.96 M | -63.64% | 0.32% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 284,148 | $7.59 M | -7.70% | 0.30% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 279,125 | $7.45 M | 231.13% | 0.30% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 275,837 | $7.36 M | 26.60% | 0.29% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 268,509 | $7.17 M | -50.78% | 0.29% |
| CANDRIAM S.C.A. | 02/07/2025 | 253,965 | $6.78 M | -13.80% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edgewise Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 211 institutional investors and hedge funds held shares of Edgewise Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 15.02 M
RA CAPITAL MANAGEMENT, L.P.: 8.91 M
BlackRock Funding, Inc. /DE: 6.48 M
BAKER BROS. ADVISORS LP: 6.16 M
Novo Holdings A/S: 5 M
JANUS HENDERSON GROUP PLC: 4.98 M
105.51% of Edgewise Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 105.50 M shares in the last 24 months. This purchase volume represents approximately $2.80 B in transactions.